Hypopnea is a condition characterized by a partial decrease in breathing during sleep. Airflow does not stop completely, but it decreases by at least 30%, and this is typically accompanied by a drop in blood oxygen levels. It is most often a component of sleep apnea syndrome.
Central sleep apnea is a serious respiratory disorder caused by the brain’s inability to regularly send “breathe” signals to the respiratory muscles during sleep. Unlike the more common obstructive sleep apnea, the issue here is not a blocked airway but rather the brain’s failure to adequately regulate breathing. This condition leads to unnoticed breathing pauses at night, a drop in blood oxygen levels, and a significant deterioration in sleep quality. This condition, which is more common in individuals with a history of heart or neurological diseases, can seriously affect quality of life if not detected early.
The symptoms of central sleep apnea often progress insidiously. Recurrent breathing pauses throughout the night, sudden awakenings, a sensation of shortness of breath, morning headaches, excessive daytime sleepiness, difficulty concentrating, and fatigue are the most common complaints. In some patients, palpitations, night sweats, and difficulty concentrating may also occur. The individual is often unaware of the breathing pauses that occur at night; it is usually the spouse or family members who first notice the condition. For this reason, symptoms should not be taken lightly, and professional evaluation should not be delayed.
The causes of central sleep apnea include heart failure, a history of stroke, neurological disorders affecting the brainstem, certain medications, and exposure to high altitudes. Additionally, in a condition known as mixed sleep apnea, both obstructive and central mechanisms may occur together. A sleep study (polysomnography) is crucial for an accurate diagnosis. A detailed evaluation determines the type and severity of the apnea, allowing for the creation of a personalized treatment plan.
Identifying the underlying cause is essential during the treatment process. Positive airway pressure devices (particularly advanced systems like adaptive servo-ventilation), oxygen support, and medical interventions are among the effective treatment options. With appropriate treatment, nighttime breathing is regulated, oxygen levels are balanced, and the patient achieves a higher quality of sleep. Increased energy during the day, mental clarity, and a noticeable improvement in overall quality of life are the most significant benefits of proper treatment. Do not ignore the symptoms to protect your sleep quality and health; early evaluation is the key to a more comfortable and healthy life.
What Is Central Sleep Apnea?
Central sleep apnea is a sleep
disorder. This condition develops without a physical blockage in the airway; the underlying issue is that breathing is not adequately controlled by the brain. Recurring breathing pauses throughout the night lead to a drop in blood oxygen levels, disrupted sleep continuity, and waking up tired in the morning. Central sleep apnea, which can be associated with heart disease, neurological problems, or certain medications, is a serious health issue that can be managed with proper diagnosis and an appropriate treatment plan.
Central sleep apnea often progresses unnoticed by the individual and typically manifests through symptoms such as excessive daytime sleepiness, difficulty concentrating, morning headaches, and sudden awakenings at night. The brief pauses in breathing during sleep can cause many organs—particularly the heart and brain—to be deprived of oxygen. For this reason, early evaluation is particularly important for individuals with a history of heart failure, stroke, or neurological disorders. This condition, which can be clearly diagnosed through a sleep study, can be managed through personalized treatment plans, leading to a significant improvement in quality of life. H3: Medical Definition of Central Sleep Apnea
Central sleep apnea is a respiratory disorder of central nervous system origin characterized by the temporary, complete, or partial loss of respiratory effort during sleep. In this condition, apnea episodes occur without upper airway obstruction; the underlying pathophysiology involves the respiratory centers in the brainstem failing to send sufficient and regular signals to the diaphragm and other respiratory muscles. During polysomnography, the absence of both airflow and thoracoabdominal respiratory movements during apnea is typical. Central sleep apnea is defined as a sleep-related respiratory disorder associated with heart failure, cerebrovascular diseases, opioid use, and certain neurological disorders, and clinically characterized by oxygen desaturation and sleep fragmentation.
Central sleep apnea is classified under the heading “sleep-related breathing disorders” in the International Classification of Sleep Disorders (ICSD), and diagnostic criteria include the detection of a certain number of central apnea or hypopnea episodes per hour on polysomnography. During these episodes, both airflow and respiratory effort cease; that is, no chest or abdominal movements are observed. Pathophysiologically, mechanisms such as instability in respiratory control, changes in chemoreceptor sensitivity, and circulatory delay may play a role. This clinically significant condition can be classified into primary (idiopathic) or secondary forms depending on the underlying cause and requires a detailed multidisciplinary evaluation for appropriate treatment planning.
Difference from Obstructive Sleep Apnea
The fundamental difference between obstructive sleep apnea and central sleep apnea lies in the cause of the cessation of breathing. In obstructive sleep apnea, the problem is the narrowing or complete blockage of the upper airway; the person attempts to breathe, but airflow does not occur due to a mechanical obstruction, and chest and abdominal movements continue during this time. In central sleep apnea, however, the airway is open, but because the brain does not send sufficient signals to the respiratory muscles, both airflow and the effort to breathe temporarily
disappear. In other words, in the obstructive type, “there is an effort to breathe but no airflow,” while in the central type, “the command to breathe does not occur.” The polysomnography performed during the diagnostic process clearly distinguishes these two conditions by analyzing respiratory movements, and the treatment approach also varies depending on the underlying mechanism.
Although the two conditions may lead to similar complaints in terms of clinical symptoms, treatment strategies differ because the underlying mechanisms are distinct. While obstructive sleep apnea is typically characterized by loud snoring and significant airway collapse, snoring may be less pronounced in central sleep apnea, and the condition is often associated with heart failure, neurological disorders, or certain medications. While the primary goal in the obstructive type is to keep the airway open, in the central type, the focus is on stabilizing respiratory control and treating the underlying cause. Therefore, accurate differentiation is critical for developing an effective and personalized treatment plan.
The Relationship Between Apnea and Hypopnea
Apnea and hypopnea are the two primary components of sleep-related breathing disorders and are typically evaluated together. Apnea is defined as a complete cessation of breathing for at least 10 seconds, whereas hypopnea involves a significant reduction in airflow rather than a complete cessation. In both cases, a drop in blood oxygen levels and disruption of sleep continuity may occur. The frequency of these events is measured by the Apnea-Hypopnea Index (AHI), and the severity of sleep apnea is determined based on this total value.
Although apnea and hypopnea are clinically distinct, their physiological effects can lead to similar outcomes. Recurrent breathing pauses or episodes of shallow breathing place a burden on the cardiovascular system, cause micro-awakenings throughout the night, and pave the way for daytime complaints such as excessive sleepiness, decreased attention, and fatigue. For this reason, not only complete breathing pauses but also partial reductions play a significant role in diagnosis and treatment planning; through a comprehensive sleep test, both conditions are analyzed in detail to determine the appropriate treatment approach.
What Are the Symptoms of Central Sleep Apnea?
Symptoms of central sleep apnea often go unnoticed during the night but can seriously affect both nighttime sleep and daytime quality of life. Recurrent cessation or irregularity of breathing prevents the body from receiving sufficient oxygen and leads to frequent awakenings. Over time, this condition can result in chronic fatigue, attention problems, and increased cardiovascular burden. The most common symptoms include:
- Repeated pauses in breathing during sleep,
- Sudden awakenings and a sensation of shortness of breath,
- Irregular or shallow breathing throughout the night,
- Morning headaches,
- Waking up feeling unrested and chronic fatigue,
- Excessive daytime sleepiness,
- Difficulty concentrating and lack of focus,
- Palpitations and night sweats.
These symptoms should be evaluated with particular care in individuals with a history of heart failure or neurological disease.
What Causes Central Sleep Apnea?
Central sleep apnea occurs when the brain’s respiratory centers fail to send regular signals to the diaphragm and other respiratory muscles during sleep. In other words, the underlying issue is not an obstruction in the airway but a disruption in the neurological control of breathing. This condition typically develops due to an underlying disease or physiological imbalance and is often seen in conjunction with problems related to the cardiovascular or nervous systems.
One of the most common causes is heart failure; prolonged circulation time and fluctuations in blood carbon dioxide levels can affect respiratory control. Stroke, tumors affecting the brainstem, or neurological diseases can also disrupt the respiratory center, leading to central apnea. Additionally, certain medications, such as opioid-based pain relievers, can cause respiratory depression. Being at high altitudes is another factor that can trigger temporary episodes of central apnea. In some patients, however, no clear cause can be identified, and this condition is defined as idiopathic (cause-unknown) central sleep apnea.
Heart Failure
Heart failure is a chronic and serious cardiovascular disease resulting from the heart’s inability to pump blood with sufficient force to meet the body’s needs. In this condition, the amount of oxygen and nutrients delivered to tissues decreases, fluid retention may develop in the body, and organ functions are impaired. The most common symptoms include shortness of breath, fatigue, swelling in the ankles and legs, increased breathing difficulty at night, and palpitations. Shortness of breath that worsens with exertion and difficulty breathing while lying down at night (orthopnea) are typical symptoms.
It can develop due to a variety of causes, including heart failure, high blood pressure, coronary artery disease, a previous heart attack, heart valve diseases, or cardiomyopathy. This condition is also closely associated with central sleep apnea; delays in circulation and fluctuations in blood carbon dioxide levels can affect the respiratory control mechanism, leading to pauses in breathing during sleep. With early diagnosis, regular follow-up, and appropriate treatment, the progression of the disease can be slowed and quality of life improved.
Brainstem Injury
Brainstem injury is a serious neurological condition resulting from damage to the brainstem region, which controls vital functions such as breathing, heart rate, blood pressure, and consciousness. The brainstem includes the medulla oblongata, pons, and mesencephalon regions and is primarily responsible for the automatic control of breathing. Damage to this area can result from causes such as trauma, stroke, tumors, infections, or bleeding and may pose a life-threatening risk.
The most notable symptoms of brainstem injury include respiratory irregularities, difficulty swallowing, speech disorders, double vision, loss of balance, and changes in consciousness. If the respiratory center is affected, central sleep apnea may develop;
because the brain cannot send regular signals to the respiratory muscles. Diagnosis is typically made through neurological examination and imaging methods. Treatment is planned according to the cause of the injury and often requires a multidisciplinary approach
Stroke
A stroke (paralysis) is a serious neurological condition requiring urgent intervention, resulting from a sudden interruption of blood flow to the brain or bleeding in a brain vessel. As blood flow is disrupted, brain cells are deprived of oxygen, and damage can occur within minutes. The most common symptoms include drooping on one side of the face, sudden weakness or numbness in an arm or leg, speech difficulties, sudden vision loss, loss of balance, and severe headache. When these symptoms appear, seeking emergency medical care without delay is of critical importance.
Following a stroke, respiratory control may be affected in some patients; particularly in cases involving the brainstem, the risk of developing central sleep apnea may increase. When the brain centers that automatically regulate breathing are damaged, breathing pauses may occur during sleep. Therefore, it is important to evaluate stroke patients not only for neurological and cardiovascular follow-up but also for sleep disorders. Early rehabilitation and regular follow-up support both neurological recovery and overall quality of life.
Opioid and Certain Medication Use
The use of opioids and certain medications can suppress the respiratory center, potentially leading to central sleep apnea. In particular, potent opioid-derived pain relievers such as morphine, oxycodone, and fentanyl reduce the brainstem’s response to carbon dioxide. This can cause breathing to slow down, become shallow, or temporarily stop entirely during sleep. Central respiratory disorders are more common in individuals with long-term and high-dose opioid use.
In addition, certain tranquilizers, sedatives, and other pharmacological agents that suppress the central nervous system may also produce similar effects. In particular, the concurrent use of multiple respiratory depressant medications increases the risk. Therefore, sleep quality and respiratory patterns should be closely monitored in patients receiving chronic pain treatment or regularly using sedative medications. In necessary cases, adjusting the medication dose or evaluating alternative treatment options is crucial for respiratory safety.
High Altitude
High altitude refers to environments with lower oxygen pressure compared to sea level, and the body’s oxygen balance can be significantly affected, particularly at elevations above 2,000 meters. As atmospheric pressure decreases, the oxygen level in the blood drops, and the body attempts to adapt by breathing faster and deeper. However, during this adaptation process, the respiratory control mechanism may become temporarily unstable.
This imbalance can lead to periodic fluctuations in breathing rate—alternating between faster and slower rhythms—and brief pauses in breathing, particularly during sleep. This altitude-related condition is generally temporary and resolves when the individual descends to a lower elevation.
However, in sensitive individuals, central sleep apnea-like breathing patterns may emerge. Therefore, it is important for people planning to stay at high altitudes for an extended period—especially if they have heart or lung disease—to be cautious and seek medical evaluation when necessary.
Neurological Disorders
Neurological disorders encompass a broad group of conditions that affect the brain, spinal cord, and nervous system, potentially disrupting the body’s movement, sensory perception, consciousness, and autonomic functions. Conditions that specifically affect the brainstem, respiratory centers, or nerve pathways can lead to irregularities in respiratory control. Parkinson’s disease, multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), brain tumors, and certain degenerative diseases fall under this category. In such conditions, impaired nerve transmission can affect the coordination of respiratory muscles and the automatic breathing pattern.
If the respiratory center is affected, breathing may slow down, become irregular, or temporarily stop during sleep. Therefore, symptoms such as impaired sleep quality, morning headaches, excessive daytime sleepiness, and breathing irregularities should be carefully evaluated in individuals with neurological disorders. Early diagnosis and multidisciplinary follow-up are of great importance for both the management of the neurological condition and the control of potential sleep-related breathing disorders.
How Is Central Sleep Apnea Diagnosed?
The diagnosis of central sleep apnea is established through a detailed evaluation of the patient’s symptoms and objective sleep tests. First, the patient is questioned about symptoms such as nighttime breathing pauses, sudden awakenings, morning headaches, and excessive daytime sleepiness; observations from a spouse or family members also play a significant role in the diagnostic process. Underlying risk factors such as heart disease, neurological disorders, or medication use are always evaluated. However, a clinical history alone is insufficient for a definitive diagnosis.
The gold standard method for diagnosis is the overnight sleep test known as polysomnography. During this test, brain waves, respiratory movements, airflow, oxygen levels, heart rhythm, and muscle activity are recorded. In central sleep apnea, both airflow and chest-abdominal respiratory movements cease during apnea episodes; this characteristic distinguishes it from the obstructive type. In necessary cases, additional cardiac evaluations, neurological examinations, or blood tests may be performed. An accurate diagnosis is critical for determining an appropriate treatment plan.
Is Central Sleep Apnea Dangerous?
Central sleep apnea is a condition that should be taken seriously, especially if it occurs alongside an underlying heart or neurological disease. Recurrent breathing pauses during sleep lead to a drop in blood oxygen levels and an imbalance in carbon dioxide levels. This can result in heart rhythm disorders, blood pressure fluctuations, and increased strain on the heart. If left untreated over the long term, it can increase cardiovascular risks.
However, central sleep apnea is a condition that can be managed when diagnosed early and treated appropriately. The level of risk varies depending on the severity and frequency of the apnea, as well as any accompanying medical conditions. Particular attention is required for individuals with heart failure, a history of stroke, or those using opioids. Through regular evaluation and a personalized treatment plan, both potential complications can be minimized and quality of life significantly improved.
Central Sleep Apnea Treatment
Treatment for central sleep apnea primarily relies on identifying the underlying cause. This is because the condition often develops due to heart failure, neurological disorders, or medication use. Therefore, the treatment plan is tailored to the individual and targets not only the breathing pauses but also the root cause. With proper evaluation, both nighttime breathing patterns can be controlled and long-term risks can be reduced.
One of the most commonly used methods in treatment is positive pressure ventilation devices. In particular, CPAP, BiPAP, or adaptive servo-ventilation (ASV) systems may be preferred for some patients. These devices support breathing during sleep, helping to maintain stable oxygen levels. In patients with heart failure, optimizing cardiac treatment may be necessary; in cases related to opioid use, adjusting medication doses or switching to alternative treatments may be required. In some situations, supplemental oxygen therapy may also be administered.
With appropriate treatment, nighttime breathing pauses decrease, sleep quality improves, and daytime fatigue significantly improves. Most importantly, the burden on the heart and brain caused by oxygen fluctuations is reduced. Early diagnosis and regular follow-up are the most important factors in increasing treatment success; therefore, it is crucial to seek specialist evaluation without delay if symptoms are present.
CPAP and BiPAP Devices
CPAP and BiPAP devices are positive-pressure respiratory support systems used to ensure that breathing continues regularly during sleep. These devices help keep the airways open and maintain adequate oxygen intake by delivering air through a mask. They provide a more uninterrupted and restful sleep by reducing the breathing pauses that occur throughout the night, particularly in patients with sleep apnea.
CPAP (Continuous Positive Airway Pressure) provides a continuous airflow at a single, constant pressure level. It is generally the first-line treatment for obstructive sleep apnea but can also be used in some cases of central sleep apnea. BiPAP (Bilevel Positive Airway Pressure), on the other hand, applies two different pressure levels during inhalation and exhalation; the ability to adjust inspiration and expiration pressures separately offers advantages, particularly for patients with weak respiratory effort or those with a central apnea component. The appropriate device is determined based on the results of the sleep study and the patient’s clinical condition. Treatment effectiveness can be significantly improved with the correct device and proper pressure settings.
Adaptive Servo-Ventilation (ASV)
Adaptive Servo-Ventilation (ASV) is an advanced positive-pressure respiratory support device used primarily in the treatment of central sleep apnea and mixed sleep apnea. This system analyzes the patient’s breathing pattern in real time and automatically adjusts pressure based on breathing activity. It increases support pressure when breathing slows down or stops, and reduces pressure when breathing returns to normal. This provides a more physiological and balanced respiratory support.
ASV technology may be preferred for certain central sleep apnea patients with concomitant heart failure; however, it is not suitable for every patient and must be planned following a detailed cardiac evaluation. These devices can serve as an effective alternative in cases where conventional CPAP or BiPAP therapy is ineffective. With proper patient selection and appropriate pressure settings, respiratory stability can be enhanced throughout the night, and sleep quality can be significantly improved.
Treatment of the Underlying Condition
One of the most critical steps in treating central sleep apnea is the accurate identification and effective management of the underlying condition. This is because the condition often develops due to heart failure, neurological disorders, a history of stroke, or medication use. Simply suppressing breathing pauses with device therapy may not be sufficient; if the underlying cause is not controlled, the problem may persist or recur.
For example, in a patient with heart failure, optimizing cardiac treatment, regulating fluid balance, and administering appropriate medication can positively influence breathing patterns. In cases arising from opioid use, reducing the medication dose or evaluating alternative treatment options may be necessary. In neurological disorders, follow-up by the relevant specialty and the rehabilitation process are of great importance. Effective treatment of the underlying cause contributes both to a reduction in central apnea episodes and to an improvement in overall health.
Medication Management
Medication management is a crucial step in the treatment of central sleep apnea because certain medications can suppress the respiratory center and increase the frequency of apnea episodes. In particular, opioid-based pain relievers, certain sedatives, and medications that suppress the central nervous system can cause breathing to slow down or temporarily stop during sleep. Therefore, all medications the patient is taking must be reviewed in detail.
When necessary, dosage reduction can be performed under the supervision of the treating physician, medication changes can be planned, or alternative treatment options can be evaluated. However, medications must never be discontinued on one’s own; abrupt discontinuation can lead to serious health issues in some cases. With appropriate and controlled medication management, both respiratory safety can be enhanced and the frequency of central sleep apnea episodes can be reduced.
Lifestyle Changes
While lifestyle changes alone may not be sufficient for the treatment of central sleep apnea, they are important steps that support overall health and enhance treatment effectiveness. In particular, measures aimed at protecting cardiovascular health can indirectly have a positive impact on respiratory control. Establishing regular sleep schedules, maintaining an ideal weight range, and eating a balanced diet support the body’s overall physiological balance.
Limiting alcohol consumption and avoiding the use of sedative medications without a doctor’s recommendation are also important, as these substances can suppress the respiratory center. Regular physical activity can contribute to nighttime respiratory stability by improving cardiovascular capacity. Additionally, since sleeping on one’s back may increase respiratory irregularities in some patients, recommendations for appropriate sleeping positions should also be considered. When these changes are implemented alongside medical or device-based treatments, they help achieve more effective results.
Central Sleep Apnea vs. Obstructive Sleep Apnea
Although both central sleep apnea and obstructive sleep apnea are characterized by recurrent disruption of breathing during sleep, their underlying mechanisms differ. In obstructive sleep apnea, the primary issue is the narrowing or complete closure of the upper airway; the individual attempts to breathe, but airflow does not occur because the airway is blocked. In central sleep apnea, however, the airway is open, but the brain does not send sufficient signals to the respiratory muscles; consequently, both airflow and the effort to breathe temporarily cease.
In terms of symptoms, both conditions can lead to excessive daytime sleepiness, morning headaches, and attention problems. However, while loud snoring is typically prominent in the obstructive type, snoring may be less noticeable in the central type and is often associated with heart failure or neurological disorders. The diagnosis is confirmed via polysomnography, and the treatment approach is planned based on the underlying mechanism. Therefore, making the correct distinction is of great importance for effective and personalized treatment.
The Difference
| Comparison Criteria | Central Sleep Apnea | Obstructive Sleep Apnea |
| Cause | The brain’s respiratory center failing to send sufficient signals | Narrowing or blockage of the upper airway |
|
Airway Condition | Open | Partially or completely closed |
| Respiratory Effort | Absent during apnea | Present during apnea |
| Snoring | Usually not noticeable | Mostly loud |
| Comparison criterion | Central Sleep Apnea | Obstructive Sleep Apnea |
|
Most Common Risk Factors | Heart failure, neurological diseases, opioid use | Obesity, anatomical airway narrowing |
| Diagnosis | Detection of central apnea via polysomnography | Detection of obstructive apnea via polysomnography |
| Treatment Approach | Treatment of the underlying condition, BiPAP or ASV | CPAP, weight management, and surgery in some cases |
Who Is Prone to Central Sleep Apnea?
Central sleep apnea is more common in certain risk groups within the population and is generally associated with an underlying health condition. It most frequently occurs in patients with heart failure; particularly in individuals with advanced heart disease, the respiratory control mechanism becomes more sensitive. Additionally, the risk of developing central apnea increases in individuals who have had a stroke, particularly if there are lesions affecting the brainstem.
Individuals with neurological conditions are also at risk. Conditions affecting the nervous system, such as Parkinson’s disease, multiple sclerosis (MS), and ALS, can disrupt the automatic control of breathing. Furthermore, in individuals who use opioid (morphine-derived) pain relievers for extended periods, the respiratory center may be suppressed, leading to episodes of central sleep apnea.
Temporary central sleep apnea may also develop in individuals living at high altitudes or those who ascend rapidly to high altitudes. Furthermore, advanced age, male gender, and the presence of severe chronic diseases are among the factors that increase the risk. In some cases, however, no specific cause is identified, and this condition is classified as idiopathic (cause-unknown) central sleep apnea.
In summary, careful evaluation for central sleep apnea is particularly important in individuals with heart, brain, or nervous system disorders, as well as those taking medications that affect the respiratory center. Early diagnosis plays a critical role in preventing potential complications